Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655

A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS

J.T. LITCHFIELD, Frank Wilcoxon · Journal of Pharmacology and Experimental Therapeutics · 1949 · 7.3K citations

Public Health, Biostatistics, Pharmacology +12

COMPARATIVE ASSAYS OF ANTIEPILEPTIC DRUGS IN MICE AND RATS

Ewart A. Swinyard, W. Carson Brown · Journal of Pharmacology and Experimental Therapeutics · 1952 · 641 citations

Medicine, Neurology, Pharmacology +13

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

Sean D. Donevan, Michael A. Rogawski · Neuron · 1993 · 359 citations

Medicine, Neuroscience, Pharmacology +15

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice

Astrid G. Chapman, Stuart E. Smith, Brian S. Meldrum · Epilepsy Research · 1991 · 193 citations

Medicine, Neuroscience, Pharmacology +12

Activity of 2,3-benzodiazepines at Native Rat and Recombinant Human Glutamate Receptors In Vitro : Stereospecificity and Selectivity Profiles

David Bleakman, Barbara A. Ballyk, Darryle D. Schoepp et al. · Neuropharmacology · 1996 · 193 citations

Life Sciences, Neuroscience, Pharmacology +16